286 related articles for article (PubMed ID: 15982301)
1. A guide to assessing damage response pathways of the hair follicle: lessons from cyclophosphamide-induced alopecia in mice.
Hendrix S; Handjiski B; Peters EM; Paus R
J Invest Dermatol; 2005 Jul; 125(1):42-51. PubMed ID: 15982301
[TBL] [Abstract][Full Text] [Related]
2. Development of a Model for Chemotherapy-Induced Alopecia: Profiling of Histological Changes in Human Hair Follicles after Chemotherapy.
Yoon JS; Choi M; Shin CY; Paik SH; Kim KH; Kwon O
J Invest Dermatol; 2016 Mar; 136(3):584-92. PubMed ID: 26774950
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment of epidermal growth factor promotes primary hair recovery via the dystrophic anagen pathway after chemotherapy-induced alopecia.
Paik SH; Yoon JS; Ryu HH; Lee JY; Shin CY; Min KH; Jo SJ; Kim KH; Kwon O
Exp Dermatol; 2013 Jul; 22(7):496-9. PubMed ID: 23800066
[TBL] [Abstract][Full Text] [Related]
4. A new strategy for modulating chemotherapy-induced alopecia, using PTH/PTHrP receptor agonist and antagonist.
Peters EM; Foitzik K; Paus R; Ray S; Holick MF
J Invest Dermatol; 2001 Aug; 117(2):173-8. PubMed ID: 11511291
[TBL] [Abstract][Full Text] [Related]
5. Hair growth modulation by topical immunophilin ligands: induction of anagen, inhibition of massive catagen development, and relative protection from chemotherapy-induced alopecia.
Maurer M; Handjiski B; Paus R
Am J Pathol; 1997 Apr; 150(4):1433-41. PubMed ID: 9094998
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced alopecia in mice. Induction by cyclophosphamide, inhibition by cyclosporine A, and modulation by dexamethasone.
Paus R; Handjiski B; Eichmüller S; Czarnetzki BM
Am J Pathol; 1994 Apr; 144(4):719-34. PubMed ID: 8160773
[TBL] [Abstract][Full Text] [Related]
7. Lower proximal cup and outer root sheath cells regenerate hair bulbs during anagen hair follicle repair after chemotherapeutic injury.
Huang WY; Hong JB; Chang M; Wang SY; Lai SF; Chien HF; Lin SJ
Exp Dermatol; 2021 Apr; 30(4):503-511. PubMed ID: 32781495
[TBL] [Abstract][Full Text] [Related]
8. Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage.
Ohnemus U; Unalan M; Handjiski B; Paus R
J Invest Dermatol; 2004 Jan; 122(1):7-13. PubMed ID: 14962083
[TBL] [Abstract][Full Text] [Related]
9. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model.
Katikaneni R; Ponnapakkam T; Matsushita O; Sakon J; Gensure R
Anticancer Drugs; 2014 Jan; 25(1):30-8. PubMed ID: 24025564
[TBL] [Abstract][Full Text] [Related]
10. Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice.
Chen SS; Zhang Y; Lu QL; Lin Z; Zhao Y
Environ Toxicol Pharmacol; 2016 Sep; 46():270-276. PubMed ID: 27522546
[TBL] [Abstract][Full Text] [Related]
11. Do hair bulb melanocytes undergo apoptosis during hair follicle regression (catagen)?
Tobin DJ; Hagen E; Botchkarev VA; Paus R
J Invest Dermatol; 1998 Dec; 111(6):941-7. PubMed ID: 9856800
[TBL] [Abstract][Full Text] [Related]
12. Human placenta induces hair regrowth in chemotherapy-induced alopecia via inhibition of apoptotic factors and proliferation of hair follicles.
Kim MH; Kim K; Lee H; Yang WM
BMC Complement Med Ther; 2020 Jul; 20(1):230. PubMed ID: 32689985
[TBL] [Abstract][Full Text] [Related]
13. Reduction of intrafollicular apoptosis in chemotherapy-induced alopecia by topical calcitriol-analogs.
Schilli MB; Paus R; Menrad A
J Invest Dermatol; 1998 Oct; 111(4):598-604. PubMed ID: 9764839
[TBL] [Abstract][Full Text] [Related]
14. Topical calcitriol enhances normal hair regrowth but does not prevent chemotherapy-induced alopecia in mice.
Paus R; Schilli MB; Handjiski B; Menrad A; Henz BM; Plonka P
Cancer Res; 1996 Oct; 56(19):4438-43. PubMed ID: 8813138
[TBL] [Abstract][Full Text] [Related]
15. Dissecting the impact of chemotherapy on the human hair follicle: a pragmatic in vitro assay for studying the pathogenesis and potential management of hair follicle dystrophy.
Bodó E; Tobin DJ; Kamenisch Y; Bíró T; Berneburg M; Funk W; Paus R
Am J Pathol; 2007 Oct; 171(4):1153-67. PubMed ID: 17823286
[TBL] [Abstract][Full Text] [Related]
16. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages.
Müller-Röver S; Handjiski B; van der Veen C; Eichmüller S; Foitzik K; McKay IA; Stenn KS; Paus R
J Invest Dermatol; 2001 Jul; 117(1):3-15. PubMed ID: 11442744
[TBL] [Abstract][Full Text] [Related]
17. Pathobiology of chemotherapy-induced hair loss.
Paus R; Haslam IS; Sharov AA; Botchkarev VA
Lancet Oncol; 2013 Feb; 14(2):e50-9. PubMed ID: 23369683
[TBL] [Abstract][Full Text] [Related]
18. A novel rat model for chemotherapy-induced alopecia.
Wikramanayake TC; Amini S; Simon J; Mauro LM; Elgart G; Schachner LA; Jimenez JJ
Clin Exp Dermatol; 2012 Apr; 37(3):284-9. PubMed ID: 22409523
[TBL] [Abstract][Full Text] [Related]
19. Effect of adenovirus-mediated expression of Sonic hedgehog gene on hair regrowth in mice with chemotherapy-induced alopecia.
Sato N; Leopold PL; Crystal RG
J Natl Cancer Inst; 2001 Dec; 93(24):1858-64. PubMed ID: 11752010
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological disruption of hair follicle pigmentation by cyclophosphamide as a model for studying the melanocyte response to and recovery from cytotoxic drug damage in situ.
Slominski A; Paus R; Plonka P; Handjiski B; Maurer M; Chakraborty A; Mihm MC
J Invest Dermatol; 1996 Jun; 106(6):1203-11. PubMed ID: 8752658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
